Falls as Innovent Takes Verzenios Rights in China
TLDR LLY falls 1.54% to $1,211.05 after a weak early trading session Innovent gains sole China commercialization rights for Verzenios Lilly keeps control of manufacturing, supply, and product development Verzenios covers early and advanced breast […]
